Literature DB >> 25517467

Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors.

Bjarki Johannesson1, Ido Sagi2, Athurva Gore3, Daniel Paull1, Mitsutoshi Yamada1, Tamar Golan-Lev2, Zhe Li3, Charles LeDuc4, Yufeng Shen5, Samantha Stern1, Nanfang Xu6, Hong Ma7, Eunju Kang7, Shoukhrat Mitalipov7, Mark V Sauer8, Kun Zhang3, Nissim Benvenisty9, Dieter Egli10.   

Abstract

The recent finding that reprogrammed human pluripotent stem cells can be derived by nuclear transfer into human oocytes as well as by induced expression of defined factors has revitalized the debate on whether one approach might be advantageous over the other. Here we compare the genetic and epigenetic integrity of human nuclear-transfer embryonic stem cell (NT-ESC) lines and isogenic induced pluripotent stem cell (iPSC) lines, derived from the same somatic cell cultures of fetal, neonatal, and adult origin. The two cell types showed similar genome-wide gene expression and DNA methylation profiles. Importantly, NT-ESCs and iPSCs had comparable numbers of de novo coding mutations, but significantly more than parthenogenetic ESCs. As iPSCs, NT-ESCs displayed clone- and gene-specific aberrations in DNA methylation and allele-specific expression of imprinted genes. The occurrence of these genetic and epigenetic defects in both NT-ESCs and iPSCs suggests that they are inherent to reprogramming, regardless of derivation approach.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25517467     DOI: 10.1016/j.stem.2014.10.002

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  50 in total

Review 1.  Present and future challenges of induced pluripotent stem cells.

Authors:  Mari Ohnuki; Kazutoshi Takahashi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-10-19       Impact factor: 6.237

Review 2.  Somatic cell nuclear transfer: origins, the present position and future opportunities.

Authors:  Ian Wilmut; Yu Bai; Jane Taylor
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-10-19       Impact factor: 6.237

Review 3.  Metabolic restructuring and cell fate conversion.

Authors:  Alessandro Prigione; María Victoria Ruiz-Pérez; Raul Bukowiecki; James Adjaye
Journal:  Cell Mol Life Sci       Date:  2015-01-14       Impact factor: 9.261

4.  The silver lining of induced pluripotent stem cell variation.

Authors:  Valentina Fossati; Tanya Jain; Ana Sevilla
Journal:  Stem Cell Investig       Date:  2016-12-06

5.  Mitochondrial DNA mutations in iPS cells: mtDNA integrity as standard iPSC selection criteria?

Authors:  Riikka H Hämäläinen
Journal:  EMBO J       Date:  2016-07-28       Impact factor: 11.598

Review 6.  Moving stem cells to the clinic: potential and limitations for brain repair.

Authors:  Julius A Steinbeck; Lorenz Studer
Journal:  Neuron       Date:  2015-04-08       Impact factor: 17.173

Review 7.  Genomic integrity of human induced pluripotent stem cells: Reprogramming, differentiation and applications.

Authors:  Clara Steichen; Zara Hannoun; Eléanor Luce; Thierry Hauet; Anne Dubart-Kupperschmitt
Journal:  World J Stem Cells       Date:  2019-10-26       Impact factor: 5.326

Review 8.  Somatic Cell Nuclear Transfer Reprogramming: Mechanisms and Applications.

Authors:  Shogo Matoba; Yi Zhang
Journal:  Cell Stem Cell       Date:  2018-07-19       Impact factor: 24.633

Review 9.  Mechanisms underlying the formation of induced pluripotent stem cells.

Authors:  Federico González; Danwei Huangfu
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-09-18       Impact factor: 5.814

Review 10.  Mitochondria in pluripotent stem cells: stemness regulators and disease targets.

Authors:  Clifford Dl Folmes; Hong Ma; Shoukhrat Mitalipov; Andre Terzic
Journal:  Curr Opin Genet Dev       Date:  2016-03-05       Impact factor: 5.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.